219600-13-2

Upstream product

• 2930-05-4 Benzyloxymethyl-oxiran 
• 7781-23-9 2,4-dimethoxy-6-methylpyrimidine 
• 100-51-6 benzyl alcohol 

Downstream Products

• 219600-14-3 6-(4-benzyloxy-3-methylthiomethoxybutyl)-2,4-dimethoxypyrimidine 
• 219600-21-2 3-benzyloxymethyl-6-bromo-1H,3H,4H,5H,8H-pyrimido<1,6-c><1,3>oxazepin-7,9-dione 
• 219600-22-3 3-benzyloxymethyl-6-methyl-1H,3H,4H,5H,8H-pyrimido<1,6-c><1,3>oxazepin-7,9-dione 
• 219600-15-4 3-benzyloxymethyl-7-methoxy-1H,3H,4H,5H-pyrimido<1,6-c><1,3>oxazepin-9-one 
• 219600-19-8 3-benzyloxymethyl-7-amino-1H,3H,4H,5H-pyrimido<1,6-c><1,3>oxazepin-9-one 
• 219600-17-6 3-benzyloxymethyl-1H,3H,4H,5H,8H-pyrimido<1,6-c><1,3>oxazepin-7,9-dione 

Relevant academic research and scientific papers

Synthesis and antiviral evaluation of 3-hydroxy-methylpyrimido[1,6-c][1,3]oxazepin derivatives

A number of pyrimido[1,6-c][1,3]oxazepin derivatives, the anti glycosidic constrained acyclic analogs of undine and cytidine have been prepared. Compounds synthesized were evaluated for activity against herpes simplex virus type 1 (HSV-1) and human cytomegalovirus (HCMV). All of these compounds were inactive.